Grace Therapeutics (GRCE) Ending Cash Balance (2011 - 2026)
Grace Therapeutics (GRCE) reported Ending Cash Balance of $16.98 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), up 0.7% from $16.86 million a year earlier and up 23.4% from the prior quarter.
Grace Therapeutics (GRCE) Ending Cash Balance (2011 - 2026) Analysis & Trends
Dating back to fiscal Q1 2012, Grace Therapeutics' Ending Cash Balance record includes 59 quarters.
- Ending Cash Balance has declined for five consecutive fiscal years, with a five-year compound annual growth rate of -19.7% (FY2021 to FY2026).
- By fiscal year, Ending Cash Balance came in at $22.13 million in FY2025 (-3.8%), $23.01 million in FY2024 (-17.5%), $27.88 million in FY2023 (-8.1%) and $30.34 million in FY2022 (-40.4%).
- Five-year quarterly Ending Cash Balance spans a low of $11.06 million in fiscal Q3 2025 and a high of $38.38 million in fiscal Q1 2023.
- Year over year, Ending Cash Balance gained in four of the last eight quarters, with an average decline of 1.8%.
- The high point for year-over-year Ending Cash Balance in five years was fiscal Q3 2026 (growth of 68.9%); the low point was fiscal Q2 2025 (a decline of 43.9%).
- Per Business Quant data, the three fiscal quarters before Q2 2027 came in at $13.76 million (Q1 2027), $16.98 million (Q4 2026) and $18.67 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Ending Cash Balance (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 4.89 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 16.91 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 10.77 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 9.65 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 7.94 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 13.19 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 6.44 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 1.88 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - | 21.31 Mn |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 16.98 Mn |
| Jun 30, 2026 | 13.76 Mn |
| Mar 31, 2026 | 16.98 Mn |
| Dec 31, 2025 | 18.67 Mn |
| Sep 30, 2025 | 16.86 Mn |
| Jun 30, 2025 | 20.01 Mn |
| Mar 31, 2025 | 22.13 Mn |
| Dec 31, 2024 | 11.06 Mn |
| Sep 30, 2024 | 15.16 Mn |
| Jun 30, 2024 | 19.39 Mn |
| Mar 31, 2024 | 23.01 Mn |
| Dec 31, 2023 | 18.55 Mn |
| Sep 30, 2023 | 26.99 Mn |
| Jun 30, 2023 | 21.63 Mn |
| Mar 31, 2023 | 27.88 Mn |
| Dec 31, 2022 | 26.24 Mn |
| Sep 30, 2022 | 26.24 Mn |
| Jun 30, 2022 | 38.38 Mn |
| Mar 31, 2022 | 30.34 Mn |
| Dec 31, 2021 | 33.01 Mn |
Grace Therapeutics Ending Cash Balance API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ending-cash-balance", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ending-cash-balance&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();